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We believe that there is great potential
in the systematic application of genomics,
proteomics, and bioinformatics to infec-
tious diseases, and that this potential has
yet to be fully realized. We suggest that the
international community unite under an
Infectious Disease Genomics Project, anal-
ogous to the Human Genome Project,
with a goal of a comprehensive, open-
access system of genomic information to
accelerate scientific understanding and
product development in the very settings
where diseases have the highest probabil-
ity of emerging. If properly structured,
such an approach could shift fundamen-
tally the global response to emerging
infectious diseases.
Genomics Is Systematically
Transforming Medicine
The ‘‘Genomic Revolution’’ has trans-
formed our vision and understanding of
how living organisms and systems interact
with each other and with the environment
[1]. Increasingly, the science of genomics
serves as the foundation for translational
research for advancing the management of
many important diseases [2–7]. Decreas-
ing costs and increasing throughput of new
technologies has made possible multina-
tional collaboration on large-scale projects
such as the Human Microbiome Project
and the 1000 Genomes Project [8–10].
Infectious disease management is also
transforming thanks to molecular technol-
ogies as seen in HIV [11,12], tuberculosis
[13,14], malaria [15,16], and other ne-
glected tropical diseases [17,18]. Discov-
ering novel pathogens and elucidating the
implications of genetic variation among
existing pathogens [19,20] is critical for
rapidly mitigating pandemic threats, as
demonstrated recently with severe acute
respiratory syndrome (SARS) [21,22] and
avian (H5N1) and pandemic H1N1 2009
influenza (commonly referred to as ‘‘swine
flu’’) [23–26].
To fully harness the benefit of genomics
in infectious diseases, a chain of overarch-
ing activities must occur. First, under-
standing the dynamics of infectious diseas-
es through the genomics lens requires a
tremendous amount of integrated com-
parative sequence, expression, epigenetic,
and proteomic data from a variety of
pathogens (bacteria, virus, protozoa, fun-
gi), vectors (arthropod and avian sources),
reservoirs (non-human mammals, environ-
ment) and human hosts. Second, generat-
ing, collating, organizing, and curating
these data is an essential public health task.
Third, translating this information to tools
to improve surveillance and response
mechanisms is critical to effectively impact
disease management.
If this bench-to-beside chain of activities
were optimized, we envision that the
following could occur:
N Fully annotated genomes of all known
pathogens, vectors, non-human hosts,
and reservoir species, as well as a large
number of candidate microbes in
families that have a high risk of
generating future pathogens, are held
in public open-access databases such as
GenBank.
N A ‘‘Genomic search’’ of all available
contextual information, from sample
origins through to published analyses,
is as simple as a Google search.
N Sequencing and other molecular tech-
nologies are everyday tools-of-the-
trade in every district hospital and
laboratory in hotspots of emerging
infectious disease, such as southeast
Asia and sub-Saharan Africa.
N Automated molecular diagnostic as-
says are low-cost, reduced at least to
the size of a smart mobile phone, and
can return definitive diagnoses of a
range of specialized known pathogen
panels at the point of care.
N A range of products that use infectious
disease genomic information routine-
ly—such as vector maps, early warning
systems, diagnostics, vaccines, and
drugs—contribute to the prediction
and prevention of epidemics.
While progress is occurring in each of
these areas, the outputs—which are need-
ed today—are far from complete.
Creating an Infectious Disease
Genomics Project (IDGP)
We believe that accelerated advances in
the area of infectious diseases can occur
under a global collaborative framework
composed of discrete and delineated
activities between the public and private
sectors among resource-wealthy and re-
source-limited settings. The Human Ge-
nome Project (HGP) was a pioneering
international effort that helped unlock the
power of genomics for human health
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information in part by having clear,
targeted outcomes and by implementing
a standard methodology across all partic-
ipants. The HGP was a great impetus for
progress seen thus far in genomics and
health. Moreover, the HGP recognized
that sequencing was just the first step in
a much bigger process [26]. A similar
effort for infectious diseases could, in our
view, help predict and prevent the next
pandemic.
To capitalize on existing successful
efforts in the area of genomics and
infectious diseases such as those by the
Broad Institute, Genomics Standards Con-
sortium, J Craig Venter Institute, the
National Institute of Allergy and Infectious
Diseases, and the Wellcome Trust Sanger
Institute (to name a few), we urge the
international community to unite its nu-
merous activities under an Infectious
Diseases Genomic Project (IDGP)—a
coordinated, large-scale, international ef-
fort focused on the genomes of pathogens,
vectors, hosts, and reservoirs and linked to
end-point surveillance and response sys-
tems. Such a project could coordinate
activities in four specific areas: generating
data, linking data, analyzing data, and
applying data (Figure 1).
Generating Data
At the outset, the IDGP would need to
determine what the world requires in
terms of genomic information. A standard
approach to generating depth and diver-
sity in genomic data is essential; beyond
this, continuous real-time surveillance and
characterization of evolving pathogens can
help effectively forestall future epidemics/
pandemics. Frontline work by consor-
tiums, genome research centers, and
individual laboratories has yielded baseline
approaches in this area and a wealth of
critical genomic information for many
important infectious agents [29–34].
While each actor in the genomics field
brings its own priority for targeting
particular pathogens or diseases, a clear
roadmap to generating a complete geno-
mic picture of all infectious agents, emerg-
ing threats, hosts, and reservoirs, incorpo-
rating a broad range of investigators with
varied technological capacity, would en-
hance both data generation and applica-
tion. Such a process allows for communi-
ty-level priority setting, thereby enabling
smaller-scale laboratories to tailor projects
to fit the needs of local communities while
contributing to global efforts.
Linking Data
The data collected must be connected
to all relevant information and analytical
tools in a single, easy-to-use, open-source,
real-time interface. Such a system would
improve on current systems by: gathering
data across the public domain and work-
ing with companies/institutions to harness
information in the private domain; linking
accurate, annotated sequencing informa-
tion to functional genomic and proteo-
mic/functional proteomic information;
attaching scientific literature associated
with all levels of information; and includ-
ing a self-sustaining financial mechanism
potentially based on royalties from com-
mercial products generated from the use of
this system.
Analyzing Data
The data need to be linked via large-
scale, dynamic databases held in virtual
servers allowing for collaboration and
sharing while maintaining originating
information for data rights and sovereign-
ty. Concurrently, these data should be
associated with a centralized collection of
open-source bioinformatics tools capable
of real-time operation in low- and high-
speed computers and varying levels of
internet connectivity. A single interface
also would bring various sample collec-
tions together in formally structured bio-
banks that capture geospatial and context
data to allow efficient scientific collabora-
tion to take place. Centralizing the entire
spectrum of information and analytic tools
also allows researchers in resource-limited
settings to participate in the genomics
revolution without prohibitively costly
machines, laboratories, and sample acces-
sibility. Although we fully acknowledge
Figure 1. A coordinated Infectious Disease Genome Project (IDGP) could unify sequencing efforts, enhance data usability, and lead
to essential tools for infectious disease management.
doi:10.1371/journal.pbio.1000219.g001
Author Summary
The world of genomics is transforming medicine, and is likely to influence the
future development of new drugs, diagnostics, and vaccines. To date, the greater
focus of genomics and medicine has been on conditions affecting resource-
wealthy settings, primarily involving scientists and companies in those settings.
However, we believe that it is possible to expand genomics into a more global
technology that can also focus on diseases of resource-limited settings. This goal
can be achieved if genomics is made a global priority. We feel one way to move in
this direction is through a comprehensive approach to infectious diseases—i.e.,
an Infectious Disease Genomics Project—that would mirror the Human Genome
Project. Without an active, unified effort specifically focused on allowing actors at
any level to participate in the genomics revolution, infectious diseases that
primarily affect the poor will likely not achieve the same level of scientific
advancement as diseases affecting the wealthy.
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that is not currently available to all, rapid
technical innovation and investment from
cheap netbook computers to new fiber
optic cables in Africa are changing that
equation. This system could be facilitated
by virtual community collaboration or
crowd-sourcing, taking full advantage of
networking tools such as Wikipedia, Face-
book, Twitter, FusionTables, and PLoS.
Applying Data
Technological advances for basic scien-
tific discovery (such as next-generation
sequencers, microarrays, mass spectrome-
ters, cell-based assay methods, and other
tools for transcriptome, metabolome, and
proteome discovery), novel techniques to
increase throughput and/or decrease the
cost of analysis, and applied clinical
decision-making and surveillance tools
(point-of-care diagnostics, rapid multi-
pathogen assays) are in progress and
should be supported actively. The IDGP
should be informed by and incorporate
emerging technology platforms to rapidly
develop more accurate field diagnostics
and to identify new opportunities for
vaccine and drug development.
Moving beyond Discourse into
Action
An IDGP is attainable if others share
this vision, show leadership, and see the
added value resulting from a coordinated
effort. The HGP certainly was a more
targeted effort and we acknowledge that
an IDGP will have additional obstacles to
overcome. Scientific disagreement over
targets is bound to occur. Complications
resulting from the proposed level of data
sharing should not be underestimated, and
care must be taken to ensure proprietary
rights and acknowledgement when war-
ranted. Adapting molecular genetic tech-
nologies to resource-limited settings is a
significant challenge, but is occurring with
some success. Bringing together a com-
munity of scientists and donors, each with
their own objectives and goals, to work
under a single framework, is a difficult
proposition. Finally, there will be many
who will find this perspective simply too
grandiose. Leaps of progress also require
big visions, however, and it may just be
possible that the 2009 H1N1 influenza
pandemic is a enough of a reminder of
what is at stake to provide a catalyst for
action.
Google.org has supported global public
health through its ‘‘Predict and Prevent’’
initiative with the aim of using the power
of information and technology to address
emerging infectious diseases by helping the
world to know where to look for these
diseases, find the threats earlier, and
respond to them faster [35]. Google.org
has focused its support on sequencing and
pathogen discovery activities, bringing
genomic technologies to resource-limited
settings in East Africa, improving surveil-
lance networks and systems, and exploring
how our core competence in internet
search can assist the infectious diseases
community [36].
As firm supporters of the open access
model for scientific publication [37],
Google.org is pleased to support this series
of essays, The Genomics of Emerging
Infectious Disease, in partnership with the
Public Library of Science (PLoS) journals
(PLoS Biology, PLoS Computational Biology,
PLoS Genetics, PLoS Medicine, PLoS Neglected
Tropical Diseases, and PLoS Pathogens), not
only to help define the current state of the
art in pathogen genomics, but also, we
hope, to stimulate debate on priorities for
research and technology development.
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